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Abstract 
Backgroud: Systemic sclerosis (SSc) caused fibrosis can be fatal and it still lack of effective treatment. Hydrogen 
sulfide (H2S) appears to be an attractive therapeutic candidates. This study aimed to investigate the protective effect 
of H2S on SSc-associated skin and lung fibrosis.
Methods:  We developed a model of SSc by subcutaneous injecting BLM to female C3H mice. The mice received 
daily subcutaneous injections of NaHS (56 and 112 μg/kg), an H2S donor. On days 7, 28, and 42, the mice were killed 
and blood samples were collected to measure the plasma H2S concentration, the skin and lung tissues was harvested 
for microscopic examination, immunohistochemistry and quantify biological parameters (hydroxyproline content, 
RT-qPCR and Western blot).
Results: In model group, the dermis of skin tissues at different time points gradually thickened, collagen deposition 
increased. The lung tissues presented pathological changes such as obvious inflammatory cell infiltration, increased 
collagen deposition and the plasma H2S concentrations points significantly decreased. Administration of NaHS mark-
edly decreased the biomarkers of fibrosis such as α-smooth muscle actin, collagen-I, collagen-III, fibronectin, trans-
forming growth factor-β1, Smad2/3 phosphorylation and inflammation including the marker protein of monocyte/
macrophage and monocyte chemoattractant protein-1 in the lung. Compared to the low dose group, the expression 
in the high dose group have decreased trend, but the difference was not significant.
Conclusion: We demonstrate the beneficial effects of H2S on SSc-associated skin and lung fibrosis. H2S may be a 
potential therapy against this intractable disease.
Keywords: Systemic sclerosis, Fibrosis, Transforming growth factor-β1, Hydrogen sulfide
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Systemic sclerosis (SSc) is a severe connective tissue dis-
ease of unknown etiology. SSc is characterized by mul-
tivisceral fibrosis resulting from inflammation, vascular 
injury and excessive collagen deposition. Skin sclerosis 
can cause discomfort and organ involvements—such as 
pulmonary fibrosis—can be fatal. However, the mecha-
nisms of fibrosis in SSc have not been fully elucidated 
and effective drugs are still scarce (Walker et  al. 2012). 
Immunosuppressants, used to treat SSc, can also cause 
important adverse effects, such as hepatic and renal func-
tional lesion, bone marrow depressions and infecting etc. 
Therefore, new therapy options need to be found.
Hydrogen sulfide (H2S) is a newly recognized endog-
enous gasotransmitter analogic to nitric oxide and car-
bon monoxide (Wang 2012). As a new emerging gaseous 
signalling molecule, for a long time, its study was lim-
ited to its toxicity. In the 1990s, it was discovered that 
endogenous H2S participated in anti-inflammation, 
anti-oxidation, and the regulation of cell proliferation 
and apoptosis (Gao et al. 2012; Moody and Calvert 2011; 
Vandiver and Snyder 2012). Past studies have confirmed 
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that exogenous H2S attenuates aortic-coarctation-
induced cardiac hypertrophy and fibrosis (Huang et  al. 
2012), inhibit renal interstitial fibrosis caused by obstruc-
tive nephropathy (Song et  al. 2014), relieve peritoneal 
mesothelial cell injury caused by high-glucose perito-
neal dialysis fluids (Lu et al. 2015) and carbon tetrachlo-
ride-induced cirrhosis (Tan et  al. 2011). The potential 
mechanisms of H2S anti-fibrotic may be account for 
inhibiting the activation and migration of inflammatory 
cells likewise myofibroblasts, subsequently decrease the 
production of pro-inflammatory cytokines and extracel-
lular matrix accumulation (Li et al. 2008; Tan et al. 2011). 
Therefore, we hypothesized that H2S may against organ 
fibrosis caused by immune reaction. Importantly, the pre-
sent of H2S in a variety of mammalian tissues and organs 
support it may be without overt adverse effect.
We conduct this study to investigate the effect of H2S 
on SSc-associated skin and lung fibrosis in mice model 
established by subcutaneous injections with BLM, and 
also examined the underlying anti-fibrotic mechanisms.
Methods
Establishment of animal models
After adaptive feeding for 1  week, 75 clean-grade 
female C3H mice with a body weight of 18–22 g (SLAC, 
Shanghai) were randomly divided into 5 groups: (1) 
control group: local subcutaneous injection of PBS 
0.1 ml + intraperitoneal injection of PBS 1 ml; (2) model 
group: local subcutaneous injection of 1  mg/ml bleo-
mycin (BLM, Nippon Kayaku Co. Ltd.) 0.1  ml  +  intra-
peritoneal injection of PBS 1 ml; (3) low dose treatment 
group: local subcutaneous injection of 1  mg/ml BLM 
0.1  ml  +  intraperitoneal injection of 56  μg/kg/d NaHS 
(Sigma, USA); (4) high dose treatment group: local sub-
cutaneous injection of 1 mg/ml BLM 0.1 ml + intraperi-
toneal injection of 112 μg/kg/d NaHS; (5) H2S group: local 
subcutaneous injection of PBS 0.1  ml +  intraperitoneal 
injection of 112  μg/kg/d NaHS. BLM (0.1  ml) dissolved 
in PBS at a concentration of 1  mg/ml, was subcutane-
ously each day for 4 consecutive weeks. Intraperitoneal 
injection of 56  μg/kg/d or 112  μg/kg/d NaHS began at 
the same time with BLM injection and lasted for 6 weeks. 
Five mice in each group were randomly sacrificed on days 
7, 28, and 42. Serum samples of mice were collected to 
measure the H2S concentrations. Skin and lung tissues of 
mice were collected for pathological staining usinghae-
matoxylin-eosin (HE) stain and Masson stain to observe 
the degrees of inflammation and fibrosis in lung tissues. 
The alkaline hydrolysis method was performed to deter-
mine the concentrations of hydroxyproline (HYP) in 
lung tissues (Jiangcheng Bioengineering Institute, Nan-
jing). PCR and western blot were performed to detect the 
expression of fibrosis indicators such as α-smooth muscle 
actin (α-SMA), collagen-I (Col-I), collagen-III (Col-III), 
fibronectin (FN), transforming growth factor-β1 (TGF-
β1) and Smad2/3 phosphorylation (p-Smad2/3). Immu-
nohistochemistry was performed to detect the expression 
of inflammatory cytokines including the marker protein 
(ED-1) of monocyte/macrophage and monocyte che-
moattractant protein-1 (MCP-1). The α-SMA, FN and 
p-Smad2/3 antibodies antibodies were purchased from 
Santa Cruz; all other antibodies were purchased from 
Abcam.
Histopathological staining
Skin tissues and left lung tissues from the injection loca-
tions in the neck and back of mice were fixed in 4  % 
paraformaldehyde, embedded in paraffin, and cut into 
5 μm sections. HE and Masson stains were performed to 
observe the changes of gross morphology, inflammation, 
and collagen deposition.
Measurement of the plasma H2S levels
The NaHS standard was used for a twofold serial dilu-
tion to obtain concentrations from 1.56 to 100 μM. The 
DNA-Az (H2S probe) was dissolved in anhydrous ethanol 
to obtain the final concentration of 2.2  mM. One black 
96-well plate was obtained, and 10  μl of 2.2  mM DNS-
Az stock solution was then added toeach well followed by 
100 μl fresh plasma or the NaHS standard immediately to 
obtaina DNS-Az concentration of 200  μM. The absorb-
ance value of each well was measured in a microplate 
reader. The excitation wavelength was 360  nm, and the 
emission wavelength was 528 nm. The NaHS results were 
used to plot a standard curve. The absorbance values of 
plasma wells were compared with the standard curve to 
obtain the plasma H2S levels.
Measurement of HYP concentration
Lung tissues of mice at a wet weight of 30–100 mg were 
collected. The HYP levels in lung tissues were detected 
using alkaline hydrolysis colorimetry. Lung tissues were 
hydrolysed using an alkaline solution. Chloramine T, 
perchloric acid, and 4-(dimethylamino) benzaldehyde 
were sequentially added. After mixing thoroughly, sam-
ples were incubated in a 60  °C water bath for 15  min. 
The samples were cooled down and centrifuged, and 
the supernatant was collected. The absorbance values 
at 550  nm wavelength and 1  cm optic path were meas-
ured. Calibration was performed using a blank tube and a 
standard tube. The results arepresented as μg/mg.
RT‑PCR
Total RNA from right lung tissues of mice was extracted 
using the TRIzol method. The concentration of the 
total RNA was measured using a spectrophotometer. 
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The synthesis of cDNA was performed according to the 
proceduresof the reverse transcription reagent kit. The 
primer sequences of β-actin, α-SMA, Col-I, and Col-III 
were synthesized by Sangon Biotech (Shanghai). Primer 
sequences are shown in Table 1.
Western blot
The frozen right lung tissues of mice were added to the 
tissue lysis solution. After homogenization and centrifu-
gation, the supernatant was collected. Protein concen-
trations were determined using the BCA method, and 
the protein samples were stored in a −80  °C freezer for 
future usage. A 10 % polyacrylamide gel was prepared for 
electrophoresis. After the samples were transferred to a 
membrane and blocked, the primary antibody was added 
(1:1000 dilution) and incubated at 4  °C overnight. The 
secondary antibody was then added (1:5000 dilution) and 
incubated at room temperature for 1 h. The results were 
developed, and fibrosis indicators such as α-SMA, FN, 
TGF-β1 and p-Smad2/3 were detected.
Immunohistochemistry
The streptavidin–biotin peroxidase complex (ABC) 
method was used for immunohistochemistry. The dilu-
tion of the primary antibodies was 1:100 for ED1and 
1:100 for MCP-1. Five fields were randomly selected 
under a microscope (400×). After the positive regions 
were localized, images were taken using a colour camera. 
The results were input into a colour image analysis sys-
tem. After the positive regions were precisely segmented, 
the quantities of ED1 and MCP-1 positive cells were 
measured, and the mean values were calculated.
Statistical analysis
Measurement data are presented as mean  ±  SD. Com-
parison among multiple groups was performed using 
one-way analysis of variance. A threshold α =  0.05 was 
used as the detection level. Data were analysed using the 
SPSS17.0 software.
Results
Pathological changes in skin tissues
HE stain and Masson stain results of skin tissues indi-
cated that the dermis of mice in the control group had 
proper thickness, clear structure, and a large amount 
of underlying adipose tissue (Fig.  1a, e). Skin tissues 
of mice in the model group at different time points 
exhibited significant thickening of the dermis and 
disordered structure with increasing model establish-
ment timethere was inflammatory cell filtration and 
collagen deposition (Fig. 1b–d, f–h). Of these features, 
the inflammatory cell infiltration was the most pro-
nounced in the 7-day group (Fig. 1b), and the collagen 
deposition and skin fibrosis were the more pronounced 
in the 28- and 42-day group (Fig.  1g, h). After NaHS 
intervention, the skin tissues of mice in the treatment 
group exhibited a clear structure, the dermis became 
thinner, the lipid layer thickened, inflammatory cell fil-
tration and collagen deposition significantly decreased 
compared to the model group on 7-day (Fig.  2c, d) 
and on 42  day (Fig.  2h, i; m, n). Compared to that in 
the low dose treatment group, the improvement in 
the high dose group was even more clearly detectable 
(Fig. 2e, j, o).
Pathological changes in lung tissues
HE stain and Masson stain results of lung tissues indi-
cated that the alveoli of mice in the control group were 
transparent and bright, the structure was intact (Fig. 1i, 
m). Compared to the control group, the model group at 
different time points all exhibited obvious inflammatory 
cell infiltration, alveolar collapse, disordered structure, 
increased collagen deposition, and thickening of alveolar 
septa (Fig. 1j–l; m, o, p). Thereinto, the inflammatory cell 
infiltration was more evident in the 7-day group (Fig. 1j); 
whereas the alveolar collapse, patchy fusion, collagen 
deposition, and pulmonary parenchymal fibrosis were 
the more evident in the 28- and 42-day group (Fig.  1o, 
p). After NaHS intervention, lung tissue pathological 
changes in mice from the treatment group were signifi-
cantly relieved, inflammatory cell filtration and collagen 
deposition decreased, alveolar structure improved, the 
alveoli were more transparent and bright, and the degree 
of inflammation and fibrosis decreased on 7-day (Fig. 3c, 
d) and on 42 day (Fig. 3h, i; m, n).
Table 1 Primers for polymerase chain reaction
α-SMA α-smooth muscle actin, Col-1 collagen-I, Col-III collagen-III
cDNA Primers Reaction condition
β-actin 5′-GTGCTATGTTGCTCTAGAC 
TTCG-3′
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Changes in the plasma H2S concentrations
Compared to the control group, the plasma H2S con-
centrations for mice in the model group at different 
time points all decreased. The mean plasma H2S con-
centration for mice in the 7-day control group was 
24.96 ± 4.12 μM. The concentration in the 7-day model 
group was 22.79 ± 1.54 μM; the concentration decreased 
compared to that in the control group, but the difference 
was not statistically significant. The concentrations in the 
28- and the 42-day control groups were 24.66 ± 3.52 and 
24.41 ± 2.57 μM, The concentrations in the 28-day model 
group and the 42-day model groups were 18.59  ±  3.32 
and 16.49 ±  2.46  μM, respectively compared to that in 
the control group, the differences were each statistically 
significant (Fig. 4).
H2S reduces the expression level of HYP in the lung tissues 
of mice induced by BLM on the 42th day
Compared to that in the control group, the HYP levels in 
the lung tissues of mice in the model group at different 
time points all significantly increased. For example in the 
42-day group, after NaHS intervention, the HYP concen-
tration in the treatment group significantly decreased. 
The decreasing trend in the high dose treatment group 
Fig. 1 HE stain and Masson stain results of skin and lung tissues in mice (×200). a–d, i–l HE stain; e–h, m–p Masson stain, a–h Skin tissues, i–p 
Lung tissues. a, e; i, m In the control group, the skin tissues had proper thickness and clear structure; the lung tissues indicated that the alveoli of 
mice were transparent and bright, the structure was intact. b, f; j, n In the 7-day Model group, the skin tissues showed little thickening and the 
inflammatory cell infiltration was the most pronounced; the inflammatory cell infiltration was more evident. c, g; k, o In the 28-day Model group, 
skin samples from the systemic sclerosis mice showed significant thickening; the lung tissues increased collagen deposition, and thickening of 
alveolar septa. d, h; l, p. In the 42-day Model group, the collagen deposition and skin fibrosis were pronounced; alveolar collapse, collagen deposi-
tion, and pulmonary parenchymal fibrosis evident
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Fig. 2 H2S improves pathological changes of skin tissues in BLM-induced mice (×200). a–j HE stain; k–o Masson stain. a–e 7-day group; f–o 42-day 
group; a, f, k In the control group, the skin tissues had proper thickness and clear structure; b, g, l In the 7-day and 42-day model group, skin tissues 
points exhibited significant thickening of the dermis and disordered structure with increasing model establishment time; c, h, m and d, i, n In the 
low and high dose treatment group, the skin tissues exhibited a clear structure, the dermis became thinner, the lipid layer thickened, inflammatory 
cell filtration and collagen deposition significantly decreased compared to the model group; e, j, o Repeated injections of NaHS had little effect 
compared with the control group
Fig. 3 H2S improves pathological changes of lung tissues in BLM-induced mice (×200). a–j HE stain; k–o Masson stain. a–e 7-day group; f–o 
42-day group; a, f, k In the control group, the lung tissues were transparent and bright; b, g, l In the 7-day and 42-day model group, points all 
exhibited obvious inflammatory cell infiltration, disordered structure, increased collagen deposition, and thickening of alveolar septa; c, h, m and d, 
i, n In the low and high dose treatment group, the above targets significantly improved. e, j, o Repeated injections of NaHS had no significant effect 
on pathological changes of lung tissues
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was more evident than that in the low dose treatment 
group, but the difference was not statistically significant 
(Fig. 5).
H2S inhibits the expression of α‑SMA, Col‑I, Col‑III and FN 
in lung tissues on the 42th day
Compared to that in the control group, the mRNA 
expression levels of α-SMA, Col-I, and Col-III in the lung 
tissues of mice in the model group at different time points 
were significantly upregulated. For example in the 42-day 
group, after NaHS intervention, the expression levels 
of the above indicators for mice in the treatment group 
were significantly downregulated, and the differences 
were statistically significant. The trend of downregulation 
in the high dose treatment group was more evident than 
that in the low dose treatment group, but the difference 
was not statistically significant (Fig. 6).
Compared to that in the control group, the protein 
expression levels of α-SMA and FN in the lung tissues of 
mice in the model group were significantly upregulated, 
and in the 42-day group after NaHS intervention, the 
expression levels of the above indicators for mice in the 
treatment group were significantly downregulated, and 
the differences were statistically significant. Compared to 
that in the low dose treatment group, the trend of down-
regulation of the expression levels of the above proteins 
in the high dose treatment group was more evident, but 
the difference was not statistically significant (Fig. 7).
H2S reduces the number of ED‑1‑positive cells 
and MCP‑1‑positive cells in lung tissues on the 7th day
Alveolitis was the most clearly observed in the 7-day 
model group. Therefore, the 7-day group was used for 
routine ED1 and MCP-1 immunohistochemistry to 
investigate the effects of H2S on inflammatory cytokines. 
The results of immunohistochemistry indicated that 
compared to the control group, the 7-day model group 
exhibited significant inflammatory cell infiltration and an 
increased number of ED1 and MCP-1 positive expression 
cells (Figs. 8b, 9b). After NaHS intervention, the expres-
sion levels of the above positive cells were significant 
downregulated (Figs.  8c, d, 9c, d). However, the differ-
ence between the low dose treatment group and the high 
dose treatment group was not statistically significant.
H2S inhibits the expression of TGF‑β1 and p‑Smad2/3 
in lung tissues on the 28th day and the 42th day
Compared to the control group, the protein expression 
levels of TGF-β1 in lung tissues of mice in the model 
group at different time points were significantly upregu-
lated, particularly the 28- and 42-day groups. After NaHS 
intervention, the protein expression level of TGF-β1 
of mice in the treatment group was significantly down-
regulated, and the difference was statistically significant; 
however, the difference between the low dose treatment 
group and the high dose treatment group was not sta-
tistically significant. Meanwhile, compared to the con-
trol group, the protein expression levels of p-Smad2/3 in 
the 42  days model group lung tissues were significantly 
upregulated. After NaHS administration, the protein 
expression level of p-Smad2/3 in the treatment group was 
Fig. 4 Changes in the plasma H2S concentrations. Compared to 
the control group, the plasma H2S concentrations for mice in the 
model group at different time points all decreased. Results represent 
mean ± SD of three independent experiments. *P < 0.05 versus 
untreated group; **P < 0.01 versus untreated group
Fig. 5 H2S reduces the expression level of HYP in the lung tissues 
of mice induced by BLM on the 42th day. Compared to the control 
group, the model group points significantly increased; After NaHS 
intervention, the HYP concentration in the treatment group signifi-
cantly decreased. The decreasing trend in the high dose treatment 
group was more evident than that in the low dose treatment group. 
Data are presented as the mean ± SD. ***P < 0.001 versus control 
group. ###P < 0.001 versus modle group
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significantly downregulated, and the difference was sta-
tistically significant (Fig. 10).
Discussion
The present study demonstrated that inflammatory cell 
infiltration in skin and lung tissues increases and the syn-
thesis of fibrogenic cytokines increases in a BLM-induced 
SSc mice model. Previous studies have suggested that 
exogenous H2S exerted a protective effect of pulmonary 
fibrosis by attenuating lipid peroxidation injury (Fang 
et  al. 2009). And this study confirmed that exogenous 
H2S could relieve SSc through an anti-inflammation and 
anti-fibrosis mechanism, which provided a novel thera-
peutic approach to SSc.
In the present study, the mice model of SSc was estab-
lished by subcutaneous injection of BLM. Consistent 
with previous studies (Yamamoto and Nishioka 2002; 
Yamamoto et al. 1999), we could observe the destruction 
of the structure of skin and lung tissues, such as disor-
dered structure, increased inflammatory cell infiltration, 
collagen deposition, significant skin and pulmonary 
fibrosis in mice from the model group at different time 
points. Furthermore, studies confirmed that the skin and 
lung tissues of SSc mice exhibited increased inflamma-
tory cell filtration and upregulation of TGF-β1 expression 
at the early stage (Bienkowski and Gotkin 1995; Bon-
niaud et al. 2005). This study confirmed that BLM could 
induce inflammatory cell filtration and increase of the 
expression of fibrogenic factors in skin and lung tissues, 
these findings were consistent with previous studies indi-
cated that the SSc mice model induced by BLM in this 
study was successfully established.
The relation of H2S and SSc associated fibrosis is not 
well defined. The results of this study suggested that the 
Fig. 6 H2S inhibits the expression of α-SMA, Col-I and Col-III in lung tissues on the 42th day. α-SMA, Col-I and Col-III mRNA were semi-quantified. 
Results represent mean ± SD of three independent experiments. ***P < 0.001 versus untreated group; ###P < 0.001 versus modle group; ##P < 0.01 
versus modle group
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plasma H2S levels are decreased in the model group after 
subcutaneous injection of BLM. Which was consistent 
with the conclusion of previous studies showing that 
“organ fibrosis might be associated with H2S deficiency” 
(El-Seweidy et  al. 2011; Tan et  al. 2011). Therefore, we 
investigate the role of H2S on SSc-associated skin and 
lung fibrosis.
Our study indicate that H2S exhibited an anti-inflam-
matory property by reducing macrophage recruitment in 
lung tissues. The inflammatory cytokines such as ED-1 
and MCP-1 were downregulated by NaHS in the 7-day 
group. Substantial data have suggested that H2S is pro-
tective against inflammation in multiple fibrosis-related 
diseases (Babaei-Karamshahlou et  al. 2012; Huang et  al. 
2012; Lu et  al. 2015; Song et  al. 2014; Whiteman and 
Winyard 2011). Our team previous study indicated that 
administration at a relatively low dose (56 μg/kg/d) exog-
enous H2S could inhibit renal interstitial mononuclear 
cell infiltration and TNF-α expression in a unilateral 
ureteral obstructive (UUO) model, suggesting that H2S 
could exert its anti-inflammation function through the 
inhibition of the activation of macrophages (Song et  al. 
Fig. 7 H2S reduces the expression of α-SMA and FN in lung tissues on the 42th day. After NaHS intervention, the expression levels of α-SMA and FN 
in the lung tissues were significantly downregulated, the trend of downregulation of the expression levels of the above proteins in the high dose 
treatment group was more evident, but the difference was not statistically significant. Results represent mean ± SD of three independent experi-
ments. ***P < 0.001 versus untreated group; #P < 0.05 versus modle group; ##P < 0.01 versus modle group
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2014). Therefore, we speculated that the anti-pulmonary 
fibrosis function of H2S was associated with its anti-
inflammation function. Inflammation plays an important 
role at the initial stage of systemic sclerosis, and inflam-
matory cell infiltration is the upstream event and one of 
the significant pathological features of organ fibrosis. The 
above study indicated that H2S inhibits the progression 
of skin and lung fibrosis through its anti-inflammation 
function.
In addition to the factor of inflammatory reaction, 
cytokines particular TGF-β1 also play an important role 
in the occurrence and development of fibrosis diseases 
(Flanders and Burmester 2003; Pittet et  al. 2001). Sub-
stantial data have demonstrated that TGF-β1 promotes 
the transdifferentiation of fibroblasts into myofibroblasts 
(Scotton and Chambers 2007). Our results showed that 
NaHS reduced the expression level of HYP and sup-
pressed mRNA and protein expressions of a-SMA, FN, 
Col-1and Col-3 induced by BLM in the lung tissues. 
Importantly, NaHS also attenuated the protein expres-
sions of TGF-β1 at 28 and 42 days. These data suggested 
that H2S inhibited the fibroblast differentiation and 
extracellular matrix production partially by blocking the 
expression of TGF-β1. It is well known that TGF-β1 to 
be working main through its signal protein p-Smad2/3. 
Our study showed that after NaHS administration, the 
protein expression level of p-Smad2/3 in the treatment 
group was significantly downregulated on day 42. These 
results consistent with the previous study (Bei et  al. 
2013). This finding suggests that the anti-fibrotic effect 
of H2S may be connected with its inhibition of TGF-β/
Smads pathway.
Fig. 8 H2S reduces the number of ED-1-positive cells in lung tissues on the 7th day. a–e Immunohistochemistry staining of ED-1. a In the control 
group, ED-1-positive cells in the interstitial tissue were rare; b In the model group, the number of ED-1-positive cells were significantly increased; c, 
d In the treatment group, comparison with the model group, the RA contained significantly fewer ED-1-positive cells in the lung tissues; e In the 
NaHS group, ED-1-positive cells were equivalent to that of control mice. Data are presented as the mean ± SD. ***P < 0.001 versus control group. 
###P < 0.001 versus modle group
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The above study confirmed that exogenous H2S had a 
protective function on SSc-related organ fibrosis. And 
importantly the present of H2S in a variety of mam-
malian tissues and organs support it may be without 
overt adverse effect. However, currently acquirable H2S 
donors like NaHS used in present study are not suitable 
for therapy because they release H2S uncontrolled. Tries 
are being made to obtain more appropriate H2S precur-
sors for therapeutic aim. GYY4137 and SG1002 are two 
administrated H2S-releasing compounds that have been 
proven to be beneficial in various diseases such as hepa-
tocellular carcinoma, diabetes, and chronic heart failure 
(Kondo et al. 2013; Lu et al. 2014; Wei et al. 2014). Such 
compounds may become useful for treatment of SSc-
related organ fibrosis.
Conclusions
In conclusions, this study confirmed that H2S could 
improve SSc-related organ fibrosis. The mechanism 
was achieved through the inhibition of the inflamma-
tory reaction and the reduction of TGF-β1 expression, 
thus reducing the accumulation of extracellular matrix. 
This study provides new insight into the treatment of 
SSc-related organ fibrosis in the clinic. A detailed under-
standing of the molecular mechanism and the related cell 
signalling pathways still awaits further study.
Fig. 9 H2S reduces the number of MCP-1-positive cells in lung tissues on the 7th day. a–e Immunohistochemistry staining of MCP-1. a In the 
control group, few MCP-1-positive cells were present in the lung tissues. b In the model group, note the strong expression of MCP-1-positive cells in 
the markedly thickened submesothelial compact zone; c, d In the treatment group, comparison with the model group, the racontained significantly 
fewer MCP-1-positive cells in the lung tissues; e In the NaHS group, MCP-1-positive cells were similar to that of control mice. Data are presented as 
the mean ± SD. ***P < 0.001 versus control group. ###P < 0.001 versus modle group
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